Tilray Target 4.5Bullish divergence Nice geometry Should close weekly bull Target is 4.5 this quarter GRI 2023by Great_Reset_InvestingUpdated 3
Tlry earningsTlry will report earnings next week. Support and resistance are shown and can potentially hit $3.32 which is apart of the resistance line and 50 EMA. If it can break above that, we can see this hit around the $4.50 range. If the earnings are bad this can go back down to its support around $2.48-2.34.by dwa49493
TLRY earnings on MondayTLRY Q2 November 2022 earnings are on Monday 1/9/2023 at 7am. Tilray Brands (TLRY) reported a Q1 August 2022 loss of $0.08 per share on revenue of $153.2 million. The consensus estimate was a loss of $0.06 per share on revenue of $155.7 million. Revenue fell 8.8% compared to the same quarter a year ago. The company said it continues to expect Adjusted EBITDA of $70 million to $80 million for the year ending December 31, 2022. I'm posting this as a long because of the higher probability, lower risk, current technical setup entry point. TLRY at $2.75 is near its major support level on the TTCATR(beta) indicator, plus there's a bullish cross setup on piRSI indicator now also. Here's TLRY levels on the 1-day chart: Q2 November 2022 consensus: EPS = -$0.05 Revenue = $158.29M SMA200 = $4.07 SMA20 Triangular Trend Channel ATR(beta): top = $4.92 R3 = $4.62 R2 = $4.32 R1 = $4.03 pivot = $3.73 S1 = $3.43 S2 = $3.13 S3 = $2.83 bottom = $2.53 Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends... *3x lucky 7s of trading* 7pt Trading compass: Price action, entry/exit Volume average/direction Trend, patterns, momentum Newsworthy current events Revenue Earnings Balance sheet 7 Common mistakes: +5% portfolio trades, capital risk management Beware of analyst's motives Emotions & Opinions FOMO : bad timing, the market is ruthless, be shrewd Lack of planning & discipline Forgetting restraint Obdurate repetitive errors, no adaptation 7 Important tools: Trading View app!, Brokerage UI Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big, organized desk Reading books, playing chess Sorted watch-list Checkout my indicators: Fibonacci VIP - volume Fibonacci MA7 - price pi RSI - trend momentum BBMC - bollinger bands TTC - trend channel AlertiT - notification tickerTracker - MFI Oscillator www.tradingview.comLongby Options360446
TLRY Tilray Brands One of My TOP Stock Picks for 2023TLRY Tilray Brands is close to the pandemic low on a huge Falling Wedge and a Double Bottom Chart Pattern. Looking at the TLRY Tilray Brands options chain, I would buy the $3 strike price Calls with 2023-1-20 expiration date for about $0.16 premium. TLRY Tilray Brands is One of My TOP Stock Picks for 2023! Looking forward to read your opinion about it.Longby TopgOptions4418
Weed companies are going to zero?TILRAY. Weekly chart. Fake CHoC and feak breakout. Hope you have an opportunity to SELL it. After 2.64 you have fib levels on 1.48 and who knows whats next. We also have large weekly support ar 2.43, so be careful there. We can touch it and then rebounce until 5.12 which is obviuosly Bullish CHoC. SUMM: SHORT — NOW STOP 5.12 LONG — ONLY IF IT BREAKS 5.12Shortby KirillARTUpdated 335
GANJsterNot much point explaining why But even u simpletons can see it’s trying to put in a higher low And I think a monster breakout is coming next year Could be a face ripping move … GRI 2022 Right that’s all your getting out of me Longby Great_Reset_InvestingUpdated 669
TLRY LongThe Play TLRY has had a 30%+ pullback from the recent highs stemming from the December 2, 2022, recent legislation that was signed by President Biden. The strategy is to take advantage of a likely 10-15% rally in the short term. Legislation: Highlights After unanimous consent from the Senate, President Biden signed into law the Medical Marijuana and Cannabidiol Research Expansion Act, an act aimed at providing federal support to facilitate research of cannabis and its potential health benefits. Legislation: Who’s Impacted The medical community, including researchers in the bio-medical field, and those interested in the pharmaceutical applications of cannabis, as well as patients in need of more treatment options. The research will also help inform lawmakers, cannabis businesses, and consumers. Things to look out for The S&P500, or the general market, is in an overall bearish trend and showing signs of resistance after a recent 2-month bull rally. About the company Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia, and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK. Longby KyleUSA8
$TLRY | Bearish Butterfly Harmonic- Short Term Bearish Butterfly Harmonic - Long Term BullishShortby Turtle2715
$TLRY Ready for Measured Move Takeoff Marijuana stocks look to have finally bottomed for a real short term rally, that can maybe turn into something else. I would think people are booking profits from being short all year and that tax loss selling in these names are done. In any case, the whole space looks ready for a real short cover rally. I have here some channel analysis that is providing some measured move targets.Longby channelguytrader10
Inverse head and shoudlers in playTilray has finally hit the local bottom and we are seeing an Inverse head and shoudlers reversal pattern. Buying here provides great risk/reward ratio however still have to pay attention to the index overall. ###NOT FINANCIAL ADVICE###Longby JoE117
Tilray for the fishermanSpecial request chart But I’m along dcaing weed stonks It looks to be breaking out This next couple of months is key Mid term target is 17.50 but if it breaks up from there and if we’re right about stonks still being bull overall and if dollar has topped- weed bubble 2.0 is a possibility GRI 2022by Great_Reset_InvestingUpdated 1110
Tilray breaking out or back to the bottom of 2.65?This is not an advice. Just a journey for myself and for those who want to share thoughts. I have been following this stock for 3 years now. Absolute bottom is 2.65, could this be broken? Will we ever see 9 again? It seems so far away. by megustadinerow335
TLRY close to breaking outIt looks like if $TLRY breaks the downtrend shortly and confirm the break out it could run up to the 200wma or longer term downtrend. With some bullish divergence on the weekly chart this adds to the bullish case.Longby Yogigolf335
TLRY - Things May Be About To Turn Bullish For WeedMulti time frame bullish RSI divergence is coming in for TLRY and could be a large pop in the pipeline. That said this one mostly takes from, not gives to buyers so a lot of care is required. Not advice.Longby dRends355510
TLRY - Looks Set To Break Out With Indexes 🚀🌒TLRY appears to be consolidating my previous first target 1:0.618 @ $3.42 just as NDX looks set to break out and so I think this is the anchoring fib that will prove to either be the bottom or a significant low. Also earnings is coming up shortly and would you believe the 1:1 fib time extension for this 3 wave pattern is almost exactly at earnings. Its as if its been scripted 😄. So I think TLRY is about to rocket 🚀. Bought LEAP puts due to high IV which can pay for my calls, alternatively can buy the stock. Not advice.Longby dRends35Updated 323223
Final Showdown Before Deadcat bounceI am waiting for the last shoe to drop before going long on the deadcat bounce.by justinl61911114
TLRY all about that 4.20I know it may seem like a joke, but actually 4.20-4.30 area is the resistance point for TLRY, over that and it could be a very large move up. Good luckLongby the_sunshipUpdated 111122
Not Out of the Wood Part 2I think we will have a deadcat bounce with the mid term election coming up and then drop right back down to all time low. $1.xx long term target for now. by justinl6196
Tilray moving averagesYesterday cannabis stocks moved higher on news. Here's TLRY moving averages on the 1-day chart: SMA50 = 3.51 SMA100 = 3.63 SMA150 = 4.35 SMA200 = 4.89 52wk high = 13.95 52wk low = 2.65 Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends... *3x lucky 7s of trading* 7pt Trading compass: Price action, entry/exit Volume average/direction Trend, patterns, momentum Newsworthy current events Revenue Earnings Balance sheet 7 Common mistakes: +5% portfolio trades, capital risk management Beware of analyst's motives Emotions & Opinions FOMO : bad timing, the market is ruthless, be shrewd Lack of planning & discipline Forgetting restraint Obdurate repetitive errors, no adaptation 7 Important tools: Trading View app!, Brokerage UI Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big, organized desk Reading books, playing chess Sorted watch-list Checkout my indicators: Fibonacci VIP - volume Fibonacci MA7 - price pi RSI - trend momentum TTC - trend channel AlertiT - notification tickerTracker - MFI Oscillator www.tradingview.comLongby Options360Updated 229
TLRY Short | LT entry target $2.08NASDAQ:TLRY Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray , Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York. TLRY Earnings are expected to be released on the 6th of October. A break below $3.08 could potential lead to an ATL of $2.08Shortby N_I_GUpdated 770
Tilray: Extended W or Head&ShouldersIt's not certain yet but I see high probability for an Extended W pattern (double bottom) or a Head&Shoulders pattern (triple bottom). First target=4.50 After the first target, there are two probabilities: A) It may break the resistance and keep on rising. B) Or, it may turn back from 4.50, form a "head and shoulders/triple bottom pattern" and then rocket! Mid & long term targets might be very high, since the share is too far away from its ATH.Longby skykhan117
TLRY (20% TRADE SETUP) Buy target is right under 3.33 when the gap closes. Sell targets are marked in orange. Red line is not accurate, it's is just there to display potential upside movement between buy target and final sell target. Longby nicktussing77Updated 3
Tilray at support? Tilray Short Term We look to Buy at 3.18 (stop at 2.94) We look to buy dips. There is scope for mild selling at the open but losses should be limited. A higher correction is expected. Expect trading to remain mixed and volatile. Previous support located at 3.120. Our profit targets will be 3.74 and 3.99 Resistance: 3.75 / 4.00 / 5.15 Support: 3.20 / 3.00 / 2.50 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses. Longby Saxo3